The ESRC EquaDem Network Plus aims to improve disparities in diagnosis and care
Category: University of Liverpool
The biotech company will develop novel therapeutic drugs for the treatment of fatal diseases
Currently the third most common cancer in the UK, lung cancer affects 40,000 people annually
Areas include health research across life stages, from paediatrics to health ageing and resilience
The project aims to advance therapeutics for tuberculosis, malaria and hepatitis C in LMICs
Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m